Add Yahoo as a preferred source to see more of our stories on Google. Visual alarms in the OIRD feature alert clinicians to condition changes and escalate as a patient’s risk increases. Credit: Masimo ...
This clearance represents the first implementation of Masimo’s OIRD detection capability in a hospital monitoring solution. By combining the trusted signal quality of best-in-class Masimo SET ® with ...
WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a ...
June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...
If you’ve ever had a medical team investigating cardiac issues, you’ve probably had a bunch of electrodes stuck all over your chest and been hooked up to an electrocardiogram. This is the gold ...
WASHINGTON – Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...
Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...
Masimo (Nasdaq:MASI) announced today that its shareholders voted in favor of the proposed acquisition of the company by Danaher (NYSE:DHR). In February, Danaher and Masimo announced an agreement that ...
The agency said the analysis of more than 300 formula samples was reassuring, but outside experts raised some concerns. By Alice Callahan When the Food and Drug Administration announced “Operation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results